Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cross

Showing results (391-400 of 595) with videos related to

Pageof 60
Sort By:
Regulatory Toxicology and Pharmacology : RTP|June 9, 2026
Exploring the Chemical Space of Pharmaceutical Extractables and LeachablesLidiya Stavitskaya, Arianna Bassan, R Daniel Mellon, et al.
Epidemiology and Infection|May 11, 2013
Subclinical infection and asymptomatic carriage of gastrointestinal zoonoses: occupational exposure, environmental pathways, and the anonymous spread of diseaseR S Quilliam, P Cross, A Prysor Williams, et al.
Acta Haematologica|March 29, 2002
Chronic eosinophilic leukaemia presenting with erythroderma, mild eosinophilia and hyper-IgE: clinical, immunological and cytogenetic features and therapeutic approach. A case reportE Granjo, M Lima, J M Lopes, et al.
Leukemia|October 31, 2008
Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1/CSF1R signaling abnormalities in the cell line GDM1A Chase, B Schultheis, S Kreil, et al.
Leukemia|August 6, 2011
Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutationG Metzgeroth, P Erben, H Martin, et al.
European Journal of Clinical Investigation|February 26, 2016
Impact of centralized evaluation of bone marrow histology in systemic mastocytosisMohamad Jawhar, Juliana Schwaab, Hans-Peter Horny, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 1999
Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3R B Pollard, D Peterson, D Hardy, et al.
Molecular Biotechnology|April 17, 2007
Simultaneous MLPA-based multiplex point mutation and deletion analysis of the dystrophin geneDavid J Bunyan, Alison C Skinner, Emma J Ashton, et al.
Epidemiology and Infection|September 28, 2011
Combining risk assessment and epidemiological risk factors to elucidate the sources of human E. coli O157 infectionO Rotariu, I D Ogden, L MacRitchie, et al.
Internet Interventions|March 4, 2022
Factors associated with treatment uptake, completion, and subsequent symptom improvement in a national digital mental health serviceShane P Cross, Eyal Karin, Lauren G Staples, et al.
Pageof 60

Showing results (391-400 of 595) with videos related to

Sort By:
Pageof 60
Regulatory Toxicology and Pharmacology : RTP|June 9, 2026
Exploring the Chemical Space of Pharmaceutical Extractables and LeachablesLidiya Stavitskaya, Arianna Bassan, R Daniel Mellon, et al.
Epidemiology and Infection|May 11, 2013
Subclinical infection and asymptomatic carriage of gastrointestinal zoonoses: occupational exposure, environmental pathways, and the anonymous spread of diseaseR S Quilliam, P Cross, A Prysor Williams, et al.
Acta Haematologica|March 29, 2002
Chronic eosinophilic leukaemia presenting with erythroderma, mild eosinophilia and hyper-IgE: clinical, immunological and cytogenetic features and therapeutic approach. A case reportE Granjo, M Lima, J M Lopes, et al.
Leukemia|October 31, 2008
Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1/CSF1R signaling abnormalities in the cell line GDM1A Chase, B Schultheis, S Kreil, et al.
Leukemia|August 6, 2011
Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutationG Metzgeroth, P Erben, H Martin, et al.
European Journal of Clinical Investigation|February 26, 2016
Impact of centralized evaluation of bone marrow histology in systemic mastocytosisMohamad Jawhar, Juliana Schwaab, Hans-Peter Horny, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 1999
Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3R B Pollard, D Peterson, D Hardy, et al.
Molecular Biotechnology|April 17, 2007
Simultaneous MLPA-based multiplex point mutation and deletion analysis of the dystrophin geneDavid J Bunyan, Alison C Skinner, Emma J Ashton, et al.
Epidemiology and Infection|September 28, 2011
Combining risk assessment and epidemiological risk factors to elucidate the sources of human E. coli O157 infectionO Rotariu, I D Ogden, L MacRitchie, et al.
Internet Interventions|March 4, 2022
Factors associated with treatment uptake, completion, and subsequent symptom improvement in a national digital mental health serviceShane P Cross, Eyal Karin, Lauren G Staples, et al.
Pageof 60